Sign In
test

Christoph Eisenring / Stefano Montalbano

Bellevue Group Ag

Assets Managed
$4.202B
Holdings
155
Last Quarter
2026 - Q1
Filed Date
11d ago
Growth Rate
-20.37%(2Q avg: -5.36%)
Sustained Growth
0 quarters

Portfolio positions

This chart displays the top 10 holdings in Bellevue Group Ag's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 155 positions.

Assets under management

The assets under management (AUM) of Bellevue Group Ag over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 4.202B in assets, with a quarterly growth rate of -20.37% and a 2-quarter average growth rate of -5.36%. The portfolio is managed by Christoph Eisenring / Stefano Montalbano, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
VRTX
Vertex Pharmaceuticals Inc
Recent Activity
Increased 0.12%
7.25%
$304.499M
681,908 shares@ $446.55 avg price
ARGX
Argenx Se - Adr
Recent Activity
Decreased -32.22%
5.44%
$228.568M
313,000 shares@ $730.25 avg price
REGN
Regeneron Pharmaceuticals
Recent Activity
Increased 1900.82%
5.13%
$215.315M
278,674 shares@ $772.64 avg price
SRRK
Scholar Rock Holding Corp
Recent Activity
Decreased -11.63%
4.2%
$176.218M
3.585M shares@ $49.16 avg price
GILD
Gilead Sciences Inc
Recent Activity
Increased 2117.7%
3.89%
$163.046M
1.17M shares@ $139.37 avg price
RVMD
Revolution Medicines Inc
Recent Activity
Decreased -69.14%
3.58%
$150.198M
1.544M shares@ $97.25 avg price
IONS
Ionis Pharmaceuticals Inc
Recent Activity
Decreased -62.12%
3.25%
$136.564M
1.819M shares@ $75.1 avg price
ISRG
Intuitive Surgical Inc
Recent Activity
Decreased -10.98%
3.15%
$132.145M
286,654 shares@ $460.99 avg price
VRDN
Viridian Therapeutics Inc
Recent Activity
Increased 54.33%
3.14%
$131.563M
6.726M shares@ $19.56 avg price
KRYS
Krystal Biotech Inc
Recent Activity
Increased 17.42%
2.97%
$124.455M
481,785 shares@ $258.32 avg price

1-10 of 155